Doubly Penalized Buckley–James Method for Survival Data with High‐Dimensional Covariates
暂无分享,去创建一个
Bin Nan | Sijian Wang | Ji Zhu | Ji Zhu | B. Nan | D. Beer | Sijian Wang | David G Beer
[1] D. Cox. Regression Models and Life-Tables , 1972 .
[2] Hongzhe Li,et al. Kernel Cox Regression Models for Linking Gene Expression Profiles to Censored Survival Data , 2002, Pacific Symposium on Biocomputing.
[3] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[4] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[5] A. Tsiatis. Estimating Regression Parameters Using Linear Rank Tests for Censored Data , 1990 .
[6] Ya'acov Ritov,et al. Estimation in a Linear Regression Model with Censored Data , 1990 .
[7] David Harrington,et al. Iterative Partial Least Squares with Right‐Censored Data Analysis: A Comparison to Other Dimension Reduction Techniques , 2005, Biometrics.
[8] Zhiliang Ying,et al. Linear regression analysis of censored survival data based on rank tests , 1990 .
[9] L. Weissfeld,et al. Estimation in linear models with censored data , 1986 .
[10] Mee Young Park,et al. L1‐regularization path algorithm for generalized linear models , 2007 .
[11] U. Alon,et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .
[13] D. Rubin,et al. Statistical Analysis with Missing Data. , 1989 .
[14] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[15] J. V. Ryzin,et al. Regression Analysis with Randomly Right-Censored Data , 1981 .
[16] J. V. Ryzin,et al. LARGE SAMPLE THEORY FOR AN ESTIMATOR OF THE MEAN SURVIVAL TIME FROM CENSORED SAMPLES , 1980 .
[17] Jiang Gui,et al. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data , 2005, Bioinform..
[18] Shuangge Ma,et al. Additive Risk Models for Survival Data with High‐Dimensional Covariates , 2006, Biometrics.
[19] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[20] Zhiliang Ying,et al. A Large Sample Study of Rank Estimation for Censored Regression Data , 1993 .
[21] Thomas S. Ferguson,et al. Large Sample Theory , 1995 .
[22] Yi Zhang,et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. , 2006, Cancer research.
[23] Jeffrey S. Simonoff,et al. A comparison of estimators for regression with a censored response variable , 1990 .
[24] D. Warburton,et al. Levels of mesenchymal FGFR2 signaling modulate smooth muscle progenitor cell commitment in the lung. , 2006, Developmental biology.
[25] Zhiliang Ying,et al. Large Sample Theory of a Modified Buckley-James Estimator for Regression Analysis with Censored Data , 1991 .
[26] F. O’Sullivan. Nonparametric Estimation of Relative Risk Using Splines and Cross-Validation , 1988 .
[27] Michael R. Green,et al. Gene Expression , 1993, Progress in Gene Expression.
[28] R. Tibshirani. The lasso method for variable selection in the Cox model. , 1997, Statistics in medicine.
[29] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] David E. Misek,et al. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. , 2002, Neoplasia.
[31] Bin Nan,et al. A Varying‐Coefficient Cox Model for the Effect of Age at a Marker Event on Age at Menopause , 2005, Biometrics.
[32] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] Rupert G. Miller. Least squares regression with censored data , 1976 .
[34] Laurence L. George,et al. The Statistical Analysis of Failure Time Data , 2003, Technometrics.
[35] Daniel T. Larose. Dimension Reduction Methods , 2006 .
[36] Lee-Jen Wei,et al. The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis. , 1992, Statistics in medicine.
[37] Hongzhe Li,et al. Dimension reduction methods for microarrays with application to censored survival data , 2004, Bioinform..
[38] D. Harrington,et al. Penalized Partial Likelihood Regression for Right‐Censored Data with Bootstrap Selection of the Penalty Parameter , 2002, Biometrics.
[39] Nicole A. Lazar,et al. Statistical Analysis With Missing Data , 2003, Technometrics.
[40] Roderick J. A. Little,et al. Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .
[41] Ian James. Accelerated Failure‐time Models , 2005 .
[42] Torsten Bohlin,et al. Large-sample theory , 1991 .
[43] I. James,et al. Linear regression with censored data , 1979 .
[44] R. Tibshirani,et al. On the “degrees of freedom” of the lasso , 2007, 0712.0881.
[45] B. Nan,et al. A hybrid Newton-type method for censored survival data using double weights in linear models , 2006, Lifetime data analysis.
[46] Jian Huang,et al. Regularized Estimation in the Accelerated Failure Time Model with High‐Dimensional Covariates , 2006, Biometrics.
[47] K. Fang,et al. Number-theoretic methods in statistics , 1993 .
[48] Ji Zhu,et al. Boosting as a Regularized Path to a Maximum Margin Classifier , 2004, J. Mach. Learn. Res..
[49] Jiang Gui,et al. Partial Cox regression analysis for high-dimensional microarray gene expression data , 2004, ISMB/ECCB.
[50] J. V. Ryzin,et al. A Buckley-James-type estimator for the mean with censored data , 1984 .
[51] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[52] David E. Misek,et al. Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas. , 2004, Clinical lung cancer.